Mr. Ian C. Read is Independent Director of KimberlyClark Corporationration Mr. Read was elected Chairman of the Board and Chief Executive Officer in December 2011 and President and Chief Executive Officer in December 2010, of Pfizer, Inc., a drug manufacturer. Mr. Read joined Pfizer in 1978 in its financial organization. He worked in Latin America through 1995, holding positions of increasing responsibility, and was appointed President of the Pfizer International Pharmaceuticals Group, Latin America/Canada in 1996. In 2000, Mr. Read was named Executive Vice President of Europe/Canada and was named a corporate Vice President in 2001. In 2006, he was named Senior Vice President of Pfizer, as well as Group President of its Worldwide Biopharmaceutical Businesses.
The company has Return on Asset of 10.2 % which means that on every $100 spent on asset it made $10.2 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 35.62 % implying that it generated $35.62 on every 100 dollars invested.
The company has 7.03 B in debt with debt to equity (D/E) ratio of 1.41 which is OK given its current industry classification. KimberlyClark Corporation has Current Ratio of 0.96 suggesting that it has not enough short term capital to pay financial commitments when the payables are due.
KimberlyClark Corporationration, together with its subsidiaries, manufactures and markets personal care, consumer tissue, and health care solutions worldwide. KimberlyClark Corporation [KMB] is traded on New York Stock Exchange in USA. It is located in Dallas, TX and employs 58,000 people. Filter other
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
NYSE KimberlyClark Corporation
-0.07%
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
Buenos-Aires
Mexico
Munich
Brussels
London
